UAB 1360: Immune Modulation by Addition of Oral Lenalidomide to Intravesical BCG (Bacille Calmette-Guerrin) for Therapy of Non-Muscle-Invasive Transitional Cell Bladder Cancer

Grant

Total Award Amount

  • 19519.00
  • Direct Costs

  • 15491.00
  • Sponsor Award Id

  • Contributor

  • Sunil Sudarshan M.D.   Investigator